Enduraphin, Inc. — Form D
Enduraphin, Inc. of Binghamton, NY, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-25. $100K was reported sold. Industry: Manufacturing.
Offering
- Filed: 2018-05-25
- Form: D
- Accession: 0001741981-18-000001
- Industry: Manufacturing
- Exemptions: 06b
- Amount sold: $100K
- Minimum investment: $10K
- Investors: 6
- Date of first sale: 2018-05-24
- Revenue range: No Revenues
- SEC file number: 021-313311
Issuer
- Name: Enduraphin, Inc.
- CIK: 0001741981
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 120 Hawley Street, Binghamton, NY, 13901
- Phone: 315-450-5009
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Michael S Dalberth | Director | Clay, NY |
| Daniel M Drake | Director | Cicero, NY |
| Michael S Dalberth | Executive Officer | Clay, NY |
| Daniel M Drake | Executive Officer | Cicero, NY |
More